Liu et al. [1] revealed that the levels of ANO1 mRNA and protein were notably elevated in metastatic prostate cancer cell lines like LNCaP and PC-3 when compared to normal cells, aligning with the clinical stages and Gleason scores of patients with prostate cancer [1]. The gene discussed is ANO1; the disease is prostate carcinoma.